MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Comprehensive loss-$16,790K (12.26%↑ Y/Y)Revenue From ContractWith Customer...$1,976K License AgreementDevelopment...$95K Knight TherapeuticsInc-License Agreement...$1K Net loss-$16,721K (12.36%↑ Y/Y)Unrealized losses onavailable-for-sale securities-$69K (-23.21%↓ Y/Y)Product IBSRELA$86,243K Product XPHOZAH$31,886K Product Supply Revenue$1,976K (-68.05%↓ Y/Y)Kyowa KirinCo.Ltd-License Agreement...$676K License$96K (380.00%↑ Y/Y)Loss beforeprovision for income taxes-$16,611K (12.93%↑ Y/Y)Provision for income taxes$110K (10900.00%↑ Y/Y)Other income, net$2,038K (7.72%↑ Y/Y)Product$118,129K (31.14%↑ Y/Y)Product And ServiceOther$2,748K (-63.77%↓ Y/Y)Gain from operations-$12,425K (13.69%↑ Y/Y)Interest expense$4,957K (13.80%↑ Y/Y)Total revenues$120,877K (23.77%↑ Y/Y)Non-cash interestexpense related to the...$1,267K (-42.90%↓ Y/Y)Total costs andoperating expenses$133,302K (33.76%↑ Y/Y)Selling, general andadministrative$101,440K (20.78%↑ Y/Y)Research and development$26,103K (66.62%↑ Y/Y)Cost of sales$5,759K (-53.57%↓ Y/Y)
Income Statement

ARDELYX, INC. (ARDX)

ARDELYX, INC. (ARDX)

source: myfinsight.com